- Global Pharma News & Resources

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020 Report -

DUBLIN--(BUSINESS WIRE)--The "Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" report has been added to's offering.

"Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020". Transdermal Drug Delivery Devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.


  • Extensive coverage of the Transdermal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Tables & Figures

2 Introduction

2.1 Transdermal Drug Delivery Overview

3 Products under Development

3.1 Transdermal Drug Delivery - Pipeline Products by Stage of Development

3.2 Transdermal Drug Delivery - Pipeline Products by Segment

3.3 Transdermal Drug Delivery - Pipeline Products by Territory

3.4 Transdermal Drug Delivery - Pipeline Products by Regulatory Path

3.5 Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date

3.6 Transdermal Drug Delivery - Ongoing Clinical Trials

4 Transdermal Drug Delivery - Pipeline Products under Development by Companies

4.1 Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development

4.2 Transdermal Drug Delivery - Pipeline Products by Stage of Development

5 Transdermal Drug Delivery Companies and Product Overview

6 Transdermal Drug Delivery- Recent Developments 2977 Appendix

7 Appendix

Companies Mentioned

  • 3M Co
  • 4P Therapeutics LLC
  • Actuated Medical Inc
  • Adynxx Inc
  • Aequus Pharmaceuticals Inc
  • Agile Therapeutics Inc
  • Allergan Ltd
  • AMW GmbH
  • AngioSoma Inc
  • Apogee Technology Inc
  • Asahi Kasei Pharma Corp
  • ASCIL Biopharm
  • Avecho Biotechnology Ltd
  • Avro Life Sciences
  • Boryung Pharmaceutical Co Ltd
  • Burke Pharmaceuticals LLC
  • Candesant Biomedical Inc
  • Cassava Sciences Inc
  • CB Scientific Inc
  • Cerimon Pharmaceuticals, Inc. (Inactive)
  • Chrono Therapeutics Inc
  • Cipla Ltd
  • Clexio Biosciences Ltd
  • Corium Inc
  • Daewoong Pharmaceutical Co Ltd
  • DBV Technologies SA
  • DD Therapeutics LLC
  • Delpor Inc
  • Dermisonics Inc (Inactive)
  • Dharma Therapeutics, Inc. (Inactive)
  • Diomics Corp
  • Drexel University
  • DURECT Corp
  • Echo Therapeutics Inc
  • Emplicure AB
  • Endo International Plc
  • Extend Biosciences Inc
  • Fe3 Medical Inc
  • Futura Medical Plc
  • Georgia Institute of Technology
  • Georgia State University
  • Hisamitsu Pharmaceutical Co Inc
  • I M Sechenov Moscow State Medical University
  • Icure Pharmaceutical Inc
  • ImmuPatch
  • Indian Institute of Science
  • Indian Institute of Technology Bombay
  • InMed Pharmaceuticals Inc
  • Institute of Materials Research & Engineering
  • Intercell AG (Inactive)
  • Interstitial NS
  • Isis Biopolymer Inc (Inactive)
  • Janisys
  • KTH Royal Institute of Technology
  • Leo Pharma AS
  • Livzon Pharmaceutical Group Co Ltd
  • Lohmann Therapie-Systeme AG
  • Luye Pharma Group Ltd
  • Massachusetts Institute of Technology
  • Mayne Pharma Group Ltd
  • Medherant Ltd
  • MEDRx Co Ltd
  • MedRx, Inc.
  • Microdermics Inc
  • Micron Biomedical Inc
  • Micropoint Technologies Pte Ltd
  • mPhase Technologies Inc
  • National University of Singapore
  • Nemaura Pharma Ltd
  • NeuroDerm Ltd
  • Nitto Denko Corp
  • North Carolina State University
  • Noven Pharmaceuticals Inc
  • NutriBand Inc
  • Nuvo Pharmaceuticals Inc
  • PassPort Technologies Inc
  • Privo Technologies Inc
  • Prometheon Pharma LLC
  • Purdue University
  • Quoin Pharmaceuticals Ltd
  • Radius Health Inc
  • Ryah Medtech Inc
  • Samyang Biopharmaceuticals Corp
  • Scilex Ltd
  • Seelos Therapeutics, Inc.
  • Shenox Pharmaceuticals LLC
  • Sinsin Pharmaceutical Co Ltd
  • SK Chemicals Co Ltd
  • Skinject Inc
  • Sparsha Pharma International Pvt Ltd
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stanford University
  • Starton Therapeutics Inc
  • Syntropharma Ltd
  • Taho Pharmaceuticals Ltd
  • Technology Health Inc
  • Teikoku Pharma USA Inc
  • tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd
  • Texas Tech University
  • The Sheikh Zayed Institute for Pediatric Surgical Innovation
  • TheraJect Inc
  • Therapeutic Systems Research Laboratories Inc
  • TheraSolve NV (Inactive)
  • Theratech, Inc.
  • Thrudermic LLC
  • Titan Pharmaceuticals Inc
  • Toa Eiyo Ltd
  • Transcu Group Limited (Inactive)
  • Transdermal Delivery Solutions Corp
  • Transdermal Specialties Inc
  • TransPharma Medical Ltd (Inactive)
  • Transport Pharmaceuticals Inc
  • University of Illinois at Chicago
  • University of Toronto
  • Vaxess Technologies Inc
  • Vaxxas Pty Ltd
  • Verndari Inc
  • ViiV Healthcare UK Ltd
  • Virpax Pharmaceuticals Inc
  • Vyteris, Inc. (Inactive)
  • Xel Pharmaceuticals Inc
  • XPhyto Therapeutic Corp
  • Zambon Italia Srl
  • Z-Cube Srl
  • ZetrOZ Inc
  • Zynerba Pharmaceuticals Inc

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 24-Oct-2021